NFC
LCTX icon

Northeast Financial Consultants’s Lineage Cell Therapeutics LCTX Stock Holding History

Northeast Financial Consultants’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-523,756
Closed -$491K – 323
2020
Q3 		$491K Hold
523,756
– – 0.04% 175
2020
Q2 		$456K Hold
523,756
– – 0.04% 178
2020
Q1 		$434K Hold
523,756
– – 0.05% 172
2019
Q4 		$466K Sell
523,756
-170,100
-25% -$142K 0.04% 189
2019
Q3 		$680K Buy
693,856
+142,000
+26% +$147K 0.07% 159
2019
Q2 		$607K Buy
551,856
+142,000
+35% +$164K 0.06% 168
2019
Q1 		$537K Buy
+409,856
New +$510K 0.06% 173
2014
Q3 		– Sell
-156,425
Closed -$385K – 142
2014
Q2 		$385K Hold
156,425
– – 0.22% 81
2014
Q1 		$415K Hold
156,425
– – 0.24% 78
2013
Q4 		$454K Buy
+156,425
New +$473K 0.3% 62

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $10.1B AUM 30.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return